Literature DB >> 19212175

A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence.

Miranda Kusters1, Geerard L Beets, Cornelis J H van de Velde, Regina G H Beets-Tan, Corrie A M Marijnen, Harm J T Rutten, Hein Putter, Yoshihiro Moriya.   

Abstract

PURPOSE: Differences exist between Japan and The Netherlands in the treatment of low rectal cancer. The purpose of this study is to analyze these, with focus on the patterns of local recurrence.
METHODS: In The Netherlands, 755 patients were operated by total mesorectal excision (TME) for low rectal cancer, 379 received preoperative radiotherapy (RT+TME). Applying the same selection criteria resulted in 324 patients in the Japanese (NCCH) group, who received extended surgery consisting of lateral lymph node dissection and a wider abdominoperineal excision. The majority received no (neo) adjuvant therapy. Local recurrence images were examined by a radiologist and a surgeon.
RESULTS: Five-year local recurrence rates were 6.9% for the Japanese NCCH group, 5.8% in the Dutch RT+TME group, and 12.1% in the Dutch TME group. Recurrence rate in the lateral pelvis is 2.2%, 0.8%, and 2.7% in the Japanese, RT+TME group, and TME group, respectively. The incidence of presacral recurrences was low in the NCCH group (0.6%), compared with 3.7% and 3.2% in the RT+TME and TME groups, respectively.
CONCLUSIONS: Both extended surgery and RT+TME result in good local control, as compared with TME alone. Preoperative radiotherapy can sterilize lateral extramesorectal tumor particles. A wider abdominoperineal resection probably results in less presacral local recurrence. Comparison of the results is difficult because of differences in patient groups.

Entities:  

Mesh:

Year:  2009        PMID: 19212175     DOI: 10.1097/SLA.0b013e318190a664

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  71 in total

1.  Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach.

Authors:  Kinuko Nagayoshi; Takashi Ueki; Tatsuya Manabe; Taiki Moriyama; Kosuke Yanai; Yoshinao Oda; Masao Tanaka
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

2.  Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.

Authors:  Ao Huang; Hongchao Zhao; Tianlong Ling; Yingjun Quan; Minhua Zheng; Bo Feng
Journal:  Int J Colorectal Dis       Date:  2014-01-03       Impact factor: 2.571

3.  Lateral lymph node dissection for lower rectal cancer.

Authors:  T Nakamura; M Watanabe
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Authors:  Seok-Byung Lim; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seong Ho Park; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2013-08-14       Impact factor: 2.571

5.  Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Authors:  Atsushi Ogura; Tsuyoshi Konishi; Chris Cunningham; Julio Garcia-Aguilar; Henrik Iversen; Shigeo Toda; In Kyu Lee; Hong Xiang Lee; Keisuke Uehara; Peter Lee; Hein Putter; Cornelis J H van de Velde; Geerard L Beets; Harm J T Rutten; Miranda Kusters
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

6.  Incidence and Predictive Model for Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer.

Authors:  Kapil Dev; K V Veerenderkumar; Swamyvelu Krishnamurthy
Journal:  Indian J Surg Oncol       Date:  2018-02-04

7.  Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin.

Authors:  F A Calvo; F Rivas; C V Sole; M Gómez-Espí; R Herranz; E Del Valle; M Rodríguez; E Alvarez
Journal:  Clin Transl Oncol       Date:  2013-10-16       Impact factor: 3.405

8.  SSAT State-of-the-Art Conference: Advances in the Management of Rectal Cancer.

Authors:  Evie Carchman; Daniel I Chu; Gregory D Kennedy; Melanie Morris; Marc Dakermandji; John R T Monson; Laura Melina Fernandez; Rodrigo Oliva Perez; Alessandro Fichera; Marco E Allaix; David Liska
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

9.  Preoperative FOLFOX in resectable locally advanced rectal cancer can be a safe and promising strategy: the R-NAC-01 study.

Authors:  Nobuki Ichikawa; Shigenori Homma; Tohru Funakoshi; Masahiro Hattori; Masanori Sato; You Kamiizumi; Kazuyoshi Omori; Masaru Nomura; Ryoichi Yokota; Masahiko Koike; Hirofumi Kon; Keisa Takeda; Hiroyuki Ishizu; Kunihiro Hirose; Daisuke Kuraya; Takahisa Ishikawa; Ryohei Murata; Hiroaki Iijima; Futoshi Kawamata; Tadashi Yoshida; Yosuke Ohno; Nozomi Minagawa; Norihiko Takahashi; Akinobu Taketomi
Journal:  Surg Today       Date:  2019-03-05       Impact factor: 2.549

Review 10.  Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.

Authors:  Y Atef; T W Koedam; S E van Oostendorp; H J Bonjer; A R Wijsmuller; J B Tuynman
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.